1695537-84-8

Basic information

• Product Name: 3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole
• Synonyms: 3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole;3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole(WXC01820)
• CAS NO: 1695537-84-8
• Molecular Formula: C27H19Br2N3O2
• Molecular Weight: 577.26666
• Mol File: 1695537-84-8.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 679.3±55.0 °C(Predicted)
• Appearance: /
• Density: 1.53±0.1 g/cm3(Predicted)
• PKA: -3.24±0.50(Predicted)
• CAS DataBase Reference: 3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole(1695537-84-8)
• EPA Substance Registry System: 3-Bromo-5-(Bromomethyl)-6-Nitro-1-Trityl-1H-Indazole(1695537-84-8)

Safety Data

• Hazardous Substances Data: 1695537-84-8(Hazardous Substances Data)

Upstream product

• 72521-00-7 5-methyl-6-nitro-1H-indazole 

Relevant articles and documents

INHIBITORS OF ERK AND METHODS OF USE

The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as ERK (MAPK). Also provided are methods of using such compounds or compositions, and methods of using these compositions to modulate the activities of one or more of these kinases, especially for therapeutic applications such as the treatment disorders such as cancer.